Pricing Log in Create free account
Saturday 17 October 2026 Export TMO’s income statement to Excel — free account

Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

690.00 6.49 −0.93%
Market cap
$257.5B
P/E
37.1×
Fwd P/E
23.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Thermo Fisher Scientific Inc. (TMO) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Thermo Fisher Scientific Inc. (TMO) trades at a EV/Sales of 6.3×. Over the past ten years it has ranged from 3.4× (September 2015) to 7.8× (November 2020); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 5.5× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 5.5× 5.75%
FY2024 5.2× (4.79%)
FY2023 5.4× 3.05%
FY2022 5.3× (28.77%)
FY2021 7.4× 23.63%
FY2020 6.0× 5.92%
FY2019 5.7× 30.63%
FY2018 4.3× (3.30%)
FY2017 4.5× 14.83%
FY2016 3.9× (1.98%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 4.8× (1.81%)
Mar 2026 4.9× (11.32%)
Dec 2025 5.5× 13.26%
Sep 2025 4.8× 16.25%
42 more quarters

Against its own ten years

Low 3.4× High 7.8×
Ten-year median 5.1×
Current reading's percentile 91

EV/Sales against peers

Company EV/Sales
IQV IQVIA Holdings Inc. compare 3.4×
TMO Thermo Fisher Scientific Inc. 6.3×
A Agilent Technologies, Inc. compare 6.9×
DHR Danaher Corporation compare 7.3×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
NTRA Natera, Inc. compare 20.5×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TMO